Entyvio (Vedolizumab) Infusions

Entyvio is a prescription medicine used in adults with Moderate to Severe Ulcerative Colitis or Crohn’s Disease. Generically referred to as vedolizumab, Entyvio belongs to a class of medications known as monoclonal antibodies, and it can be administered via injectable treatment.

Entyvio infusions work by binding to a protein on the GI-directed white blood cells, preventing an excess of white blood cells from entering the GI tract.

By blocking this substance, vedolizumab injections can help decrease swelling (inflammation) in the gut, reducing symptoms and possibly slowing or stopping the damage caused by these bowel disorders.

Drug manufacturer information for Entyvio is available here.